Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India flag India · Delayed Price · Currency is INR
103.85
-5.45 (-4.99%)
At close: Jan 23, 2026

NSE:ARISTO Revenue

Aristo Bio-Tech and Lifescience had revenue of 2.56B INR in the half year ending September 30, 2025, with 93.07% growth. This brings the company's revenue in the last twelve months to 3.60B, up 10.39% year-over-year. In the fiscal year ending March 31, 2025, Aristo Bio-Tech and Lifescience had annual revenue of 3.18B with 29.76% growth.

Revenue (ttm)
3.60B
Revenue Growth
+10.39%
P/S Ratio
0.21
Revenue / Employee
54.61M
Employees
66
Market Cap
744.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20253.18B729.45M29.76%
Mar 31, 20242.45B272.92M12.53%
Mar 31, 20232.18B520.92M31.43%
Mar 31, 20221.66B-14.55M-0.87%
Mar 31, 20211.67B-340.13M-16.90%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition